480 related articles for article (PubMed ID: 36713558)
1. Partners in crime: The feedback loop between metabolic reprogramming and immune checkpoints in the tumor microenvironment.
Benito-Lopez JJ; Marroquin-Muciño M; Perez-Medina M; Chavez-Dominguez R; Aguilar-Cazares D; Galicia-Velasco M; Lopez-Gonzalez JS
Front Oncol; 2022; 12():1101503. PubMed ID: 36713558
[TBL] [Abstract][Full Text] [Related]
2. Metabolic Reprogramming in the Tumor Microenvironment With Immunocytes and Immune Checkpoints.
Xu Y; He L; Fu Q; Hu J
Front Oncol; 2021; 11():759015. PubMed ID: 34858835
[TBL] [Abstract][Full Text] [Related]
3. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
Eskandari-Malayeri F; Rezaei M
Front Immunol; 2022; 13():996145. PubMed ID: 36275750
[TBL] [Abstract][Full Text] [Related]
4. Nutrient deprivation and hypoxia alter T cell immune checkpoint expression: potential impact for immunotherapy.
Davern M; Donlon NE; O'Connell F; Gaughan C; O'Donovan C; McGrath J; Sheppard AD; Hayes C; King R; Temperley H; MacLean M; Bulter C; Bhardwaj A; Moore J; Donohoe C; Ravi N; Conroy MJ; Reynolds JV; Lysaght J
J Cancer Res Clin Oncol; 2023 Jul; 149(8):5377-5395. PubMed ID: 36445478
[TBL] [Abstract][Full Text] [Related]
5. Metabolic programming and immune suppression in the tumor microenvironment.
Arner EN; Rathmell JC
Cancer Cell; 2023 Mar; 41(3):421-433. PubMed ID: 36801000
[TBL] [Abstract][Full Text] [Related]
6. New therapeutic targets for cancer: the interplay between immune and metabolic checkpoints and gut microbiota.
Agrawal B
Clin Transl Med; 2019 Aug; 8(1):23. PubMed ID: 31468283
[TBL] [Abstract][Full Text] [Related]
7. Tumor Microenvironment and Nitric Oxide: Concepts and Mechanisms.
Vedenko A; Panara K; Goldstein G; Ramasamy R; Arora H
Adv Exp Med Biol; 2020; 1277():143-158. PubMed ID: 33119871
[TBL] [Abstract][Full Text] [Related]
8. Metabolic Reprogramming in Tumor Immune Microenvironment: Impact on Immune Cell Function and Therapeutic Implications.
Liu Y; Zhao Y; Song H; Li Y; Liu Z; Ye Z; Zhao J; Wu Y; Tang J; Yao M
Cancer Lett; 2024 Jun; ():217076. PubMed ID: 38906524
[TBL] [Abstract][Full Text] [Related]
9. Metabolic reprogramming in the immunosuppression of tumor-associated macrophages.
Wang Y; Wang D; Yang L; Zhang Y
Chin Med J (Engl); 2022 Oct; 135(20):2405-2416. PubMed ID: 36385099
[TBL] [Abstract][Full Text] [Related]
10. Immunometabolism in the Bladder Cancer Microenvironment.
Fattahi MJ; Haghshenas MR; Ghaderi A
Endocr Metab Immune Disord Drug Targets; 2022; 22(12):1201-1216. PubMed ID: 34983357
[TBL] [Abstract][Full Text] [Related]
11. The Tumor Microenvironment Reprograms Immune Cells.
Cao H; Gao S; Jogani R; Sugimura R
Cell Reprogram; 2022 Dec; 24(6):343-352. PubMed ID: 36301256
[TBL] [Abstract][Full Text] [Related]
12. Targeting metabolism to enhance immunotherapy within tumor microenvironment.
Liang XH; Chen XY; Yan Y; Cheng AY; Lin JY; Jiang YX; Chen HZ; Jin JM; Luan X
Acta Pharmacol Sin; 2024 May; ():. PubMed ID: 38811773
[TBL] [Abstract][Full Text] [Related]
13. Tumor microenvironment signaling and therapeutics in cancer progression.
Goenka A; Khan F; Verma B; Sinha P; Dmello CC; Jogalekar MP; Gangadaran P; Ahn BC
Cancer Commun (Lond); 2023 May; 43(5):525-561. PubMed ID: 37005490
[TBL] [Abstract][Full Text] [Related]
14. The cancer metabolic reprogramming and immune response.
Xia L; Oyang L; Lin J; Tan S; Han Y; Wu N; Yi P; Tang L; Pan Q; Rao S; Liang J; Tang Y; Su M; Luo X; Yang Y; Shi Y; Wang H; Zhou Y; Liao Q
Mol Cancer; 2021 Feb; 20(1):28. PubMed ID: 33546704
[TBL] [Abstract][Full Text] [Related]
15. Manipulating Metabolic Alterations and their Consequences to Unleash the Potential of Antitumor Immunotherapy.
Zhu X; Zhu L; Wu Y
Curr Protein Pept Sci; 2022; 23(9):585-601. PubMed ID: 35726423
[TBL] [Abstract][Full Text] [Related]
16. Emerging role of metabolic reprogramming in tumor immune evasion and immunotherapy.
Fan C; Zhang S; Gong Z; Li X; Xiang B; Deng H; Zhou M; Li G; Li Y; Xiong W; Zeng Z; Li X
Sci China Life Sci; 2021 Apr; 64(4):534-547. PubMed ID: 32815067
[TBL] [Abstract][Full Text] [Related]
17. Metabolic Switch in the Tumor Microenvironment Determines Immune Responses to Anti-cancer Therapy.
Wegiel B; Vuerich M; Daneshmandi S; Seth P
Front Oncol; 2018; 8():284. PubMed ID: 30151352
[TBL] [Abstract][Full Text] [Related]
18. Exosomal cargos-mediated metabolic reprogramming in tumor microenvironment.
Tan S; Yang Y; Yang W; Han Y; Huang L; Yang R; Hu Z; Tao Y; Liu L; Li Y; Oyang L; Lin J; Peng Q; Jiang X; Xu X; Xia L; Peng M; Wu N; Tang Y; Cao D; Liao Q; Zhou Y
J Exp Clin Cancer Res; 2023 Mar; 42(1):59. PubMed ID: 36899389
[TBL] [Abstract][Full Text] [Related]
19. Metabolic alterations in the tumor microenvironment and their role in oncogenesis.
Eisenberg L; Eisenberg-Bord M; Eisenberg-Lerner A; Sagi-Eisenberg R
Cancer Lett; 2020 Aug; 484():65-71. PubMed ID: 32387442
[TBL] [Abstract][Full Text] [Related]
20. Targeting SLC1A5 and SLC3A2/SLC7A5 as a Potential Strategy to Strengthen Anti-Tumor Immunity in the Tumor Microenvironment.
Nachef M; Ali AK; Almutairi SM; Lee SH
Front Immunol; 2021; 12():624324. PubMed ID: 33953707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
